Adam Townsend

2021

In 2021, Adam Townsend earned a total compensation of $2.6M as Chief Commercial Officer at Apellis Pharmaceuticals, a 9% decrease compared to previous year.

Compensation breakdown

Bonus$144,000
Option Awards$1,617,188
Salary$448,269
Stock Awards$420,938
Other$10,424
Total$2,640,819

Townsend received $1.6M in option awards, accounting for 61% of the total pay in 2021.

Townsend also received $144K in bonus, $448.3K in salary, $420.9K in stock awards and $10.4K in other compensation.

Rankings

In 2021, Adam Townsend's compensation ranked 4,931st out of 12,415 executives tracked by ExecPay. In other words, Townsend earned more than 60.3% of executives.

ClassificationRankingPercentile
All
4,931
out of 12,415
60th
Division
Manufacturing
2,065
out of 5,508
63rd
Major group
Chemicals And Allied Products
876
out of 2,378
63rd
Industry group
Drugs
785
out of 2,099
63rd
Industry
Pharmaceutical Preparations
559
out of 1,549
64th

Pay ratio

Adam Townsend's Pay$2,640,819
Median Employee's Pay$321,867
Pay Ratio

8

to 1

In 2021, the annual total compensation of Adam Townsend was $2,640,819.

The annual total compensation of the median employee at Apellis Pharmaceuticals was $321,867.

The ratio of Adam Townsend's pay to the pay of median employee was therefore 8 to one.

Source: SEC filing on April 20, 2022.

Townsend's colleagues

We found four more compensation records of executives who worked with Adam Townsend at Apellis Pharmaceuticals in 2021.

2021

Cedric Francois

Apellis Pharmaceuticals

Chief Executive Officer

2021

Timothy Sullivan

Apellis Pharmaceuticals

Chief Financial Officer

2021

Pascal Deschatelets

Apellis Pharmaceuticals

Chief Scientific Officer

2021

Federico Grossi

Apellis Pharmaceuticals

Chief Medical Officer

News

In-depth

You may also like